{"id":"W1507518844","doi":"10.14694/edbook_am.2015.35.e504","title":"Multiple Myeloma: From Front-Line to Relapsed Therapies","year":2015,"lang":"en","type":"review","venue":"American Society of Clinical Oncology Educational Book","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Pomalidomide; Ixazomib; Lenalidomide; Thalidomide; Medicine; Carfilzomib; Multiple myeloma; Bortezomib; Oncology; Internal medicine; Proteasome inhibitor; Refractory (planetary science); Pharmacology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001152684,0.0004940454,0.005178487,0.0000965995,0.00008346426,0.000009866892,0.0004250356,0.00058317,0.001507465],"category_scores_gemma":[0.002836551,0.0003669244,0.002186495,0.0003013179,0.001460818,0.00006258921,0.0001846412,0.001070424,0.0009926802],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007921086,"about_ca_system_score_gemma":0.01318952,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007466792,"about_ca_topic_score_gemma":0.00003784709,"domain_scores_codex":[0.9950132,0.000721348,0.002168575,0.0008703578,0.0007450163,0.0004814607],"domain_scores_gemma":[0.9855405,0.01044129,0.001422552,0.0007793101,0.0007091329,0.001107201],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003268062,0.002028359,0.00286484,0.0004363208,0.002422553,0.000006524637,0.0003317654,2.472214e-7,6.517096e-7,0.0000134182,0.158236,0.8333325],"study_design_scores_gemma":[0.002578296,0.002704568,0.008553592,0.001168507,0.00114648,0.00001068028,0.0003377065,0.00001374362,4.873256e-7,0.00009802567,0.9831205,0.0002673923],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004413626,0.9774246,0.00004726587,0.01632543,0.0005500164,0.001943261,0.0004407302,0.0000434137,0.002783874],"genre_scores_gemma":[0.0000987778,0.9186809,0.05058153,0.005331981,0.001967635,0.0005151622,0.001786884,0.00007590589,0.02096123],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8330651,"threshold_uncertainty_score":0.9998783,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.216861391646842,"score_gpt":0.531727034602765,"score_spread":0.314865642955923,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}